Lincoln Pharmaceuticals gets patent for Antimalarial Drug

19 Dec 2017 Evaluate

Lincoln Pharmaceuticals has been awarded a Patent for ‘An Arteether Injection for Treatment of Malaria’ by Government of India for Antimalarial Drug. In the present time, this formulation, Arteether lnjection are available in market in 3ml and 2ml ampoules form. At the time of injecting Arteether Injection to the patient by doctors, it is very painful for a long time. Patient will have to take this injection at least for a period of three days to control the malaria.

The company’s R&D Research team has developed a painless Injection with compressed dosage form by reducing inside drug material up to 50% volume. This new Arteether Injection developed by company is available in 1 ml only. Due to this new innovation, patient will get faster relief and painless.

Lincoln Pharmaceuticals is engaged in the manufacture and marketing of affordable therapeutic products. The product range of the company includes Tablets, Capsules, Injectables, Syrups and Ointments.  


Lincoln Pharma Share Price

581.00 -1.25 (-0.21%)
08-May-2024 12:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.00
Dr. Reddys Lab 6070.75
Cipla 1397.95
Zydus Lifesciences 1002.75
Lupin 1616.15
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.